Array BioPharma To Present At The Cowen And Company Annual Healthcare Conference
March 01 2017 - 9:00AM
PR Newswire (US)
BOULDER, Colo., March 1, 2017 /PRNewswire/ -- Array
BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief
Executive Officer, Ron Squarer, will
present at the Cowen and Company Annual Healthcare Conference in
Boston. The public is welcome to participate in the
conference through a webcast on the Array BioPharma
website.
|
Event:
|
Cowen and Company
Annual Healthcare Conference
|
|
Presenter:
|
Ron Squarer, Chief
Executive Officer
|
|
Date:
|
Wednesday, March 8,
2017
|
|
Time:
|
10:00 a.m. Eastern
Time
|
|
Webcast:
|
http://wsw.com/webcast/cowen38/arry
|
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small
molecule drugs to treat patients afflicted with cancer. Seven
registration studies are currently advancing related to six cancer
drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib
(partnered with AstraZeneca), danoprevir (partnered with Roche),
larotrectinib (partnered with Loxo Oncology) and tucatinib
(partnered with Cascadian Therapeutics).
|
CONTACT:
|
Tricia
Haugeto
|
|
Array BioPharma
Inc.
|
|
303-386-1193
|
|
thaugeto@arraybiopharma.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-cowen-and-company-annual-healthcare-conference-300412128.html
SOURCE Array BioPharma Inc.
Copyright 2017 PR Newswire
Array Technologies (NASDAQ:ARRY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Array Technologies (NASDAQ:ARRY)
Historical Stock Chart
From Apr 2023 to Apr 2024
